AOC 1001 Earns Breakthrough Therapy Designation for Myotonic Dystrophy Type 1 (DM1)
Currently, there are no approved treatment options for myotonic dystrophy type 1 (DM1), a progressive neuromuscular disease. As the disease progresses, affected individuals experience muscle weakness, respiratory distress, and cardiac…